CCL4 and metabolic dysfunction-associated steatotic liver disease: A fast food diet (FFD) combined with a trace dose of CCL4 (0.5 mL/kg body weight) for 8 weeks resulted in histological features of NAFLD, including steatosis, inflammation and fibrosis, in Wistar rat models within 8 weeks, suggesting that the model has potential utility in developing NAFLD and anti-fibrosis therapy (Chheda et al., 2014).